Pacific Biosciences Of California | PACB - Cost Of Sales


Pacific Biosciences Of California reported $28.9M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 845M 7M Mar/2026
Bruker USD 443.6M 84.4M Mar/2026
Danaher USD 2.36B 512M Mar/2026
General Electric Aerospace USD 8.15B 764M Mar/2026
Illumina USD 370M 30M Mar/2026
Myriad Genetics USD 63M 1.1M Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quidel USD -79.5M 528.3M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Standard Biotools USD 9.84M 2.58M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Waters USD 725M 350.06M Mar/2026